Aripiprazole and Ziprasidone Do Not Lower Blood Pressure
Among second-generation antipsychotics, aripiprazole and ziprasidone are the agents that do NOT decrease blood pressure—in fact, they may rarely cause hypertension rather than hypotension. This distinguishes them from most other atypical antipsychotics, which commonly cause orthostatic hypotension as a side effect.
Blood Pressure Effects by Agent
Agents That DO Lower Blood Pressure (Avoid if Hypotension is a Concern)
Most second-generation antipsychotics cause hypotension through various mechanisms:
Olanzapine: Causes hypotension and bradycardia, particularly with IM administration 1. This effect is well-documented in elderly patients 1.
Quetiapine: Associated with hypotension (<10% incidence) 2. Listed among agents causing orthostatic hypotension 3.
Clozapine: Associated with hypotension (<10% incidence) 2, though interestingly may also cause hypertension in some cases 4.
Agents That Do NOT Lower Blood Pressure
Aripiprazole and ziprasidone stand apart from other second-generation antipsychotics:
Aripiprazole: Tends to have fewer metabolic effects 5 and has been documented to cause asymptomatic hypertension rather than hypotension 6. This is likely related to its unique mechanism as a partial dopamine agonist rather than a pure antagonist 7.
Ziprasidone: Demonstrated no adverse effects on blood pressure in elderly patients 1. Studies show no significant changes in blood pressure or heart rate 1. Ziprasidone may rarely cause hypertension (<2%) 2.
Clinical Reasoning
The mechanism behind these differences relates to receptor profiles. Most atypical antipsychotics cause hypotension through:
- Direct vasodilation
- Alpha-adrenergic blockade
- Histamine (H1) receptor antagonism
- Autonomic nervous system modulation
Aripiprazole's partial dopamine agonist activity and ziprasidone's distinct receptor binding profile result in minimal effects on blood pressure regulation, making them safer choices when hypotension is a concern 1, 2.
Key Clinical Pitfall
Do not assume all second-generation antipsychotics are equivalent regarding cardiovascular effects. While orthostatic hypotension is listed as a class effect for atypical antipsychotics 3, aripiprazole and ziprasidone are notable exceptions. This distinction is critical when treating patients with:
- Baseline hypotension
- Cardiovascular disease
- Elderly patients at fall risk
- Patients on concurrent antihypertensive medications
When blood pressure stability is a priority, aripiprazole or ziprasidone should be preferentially selected over olanzapine, quetiapine, risperidone, or clozapine 1, 5.